Back to search

Article

ADH4 Is A TP53-Associated Immune-Metabolic Signature For The Prediction Of Prognosis In Hepatocellular Carcinoma

2022-02-15

Abstract excerpt

<h4>Background: </h4> Tumor protein p53 (TP53) is one of the most frequent mutated genes in hepatocellular carcinoma (HCC), whose mutations influenced tumor microenvironment (TME) and are associated with a worse prognosis. Thus, finding out an accurate prognostic signature could be beneficial for improving the prognosis of HCC. <h4>Methods: </h4>: HCC genetic mutation data, transcriptome data, and clinical data we...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8537b9b4-64c3-5e57-aeb5-ece50d81d6bf
DOI
10.21203/rs.3.rs-1349677/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ADH4 Is A TP53-Associated Immune-Metabolic Signature For The Prediction Of Prognosis In Hepatocellular CarcinomaDOI 10.21203/rs.3.rs-1349677/v1
ADH4 is a TP53-associated immunometabolic signature for prediction of prognosis in hepatocellular carcinomaSemantic proximity
Alcohol dehydrogenase 4 is a TP53‑associated gene signature for the prediction of prognosis in hepatocellular carcinomaSemantic proximity
Machine learning-based transcriptome analysis of lipid metabolism biomarkers for the survival prediction in hepatocellular carcinomaSemantic proximity
Risk model of nucleotide metabolism and immunity signature genes in predicting of hepatocellular carcinoma prognosis and immune microenvironmentSemantic proximity
Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinomaSemantic proximity
A novel prognostic model for hepatocellular carcinoma based on pyruvate metabolism-related genesSemantic proximity
From genes to therapy: a lipid Metabolism-Related genetic risk model predicts HCC outcomes and enhances immunotherapySemantic proximity
A novel molecular classification based on TP53 mutation to predict bladder cancer prognosis and immunotherapy efficacySemantic proximity
Development of Prognostic Model Based on Five-gene Related to Tumor Mutation Burden in Hepatocellular CarcinomaSemantic proximity
Prognostic Implication of a Novel Metabolism-Related Gene Signature in Hepatocellular CarcinomaSemantic proximity
Fatty Acid Metabolism-Related Genes Are Potential Biomarkers for Prognostic Prediction and Clinical Guidance in Patients with Hepatocellular CarcinomaSemantic proximity
Introduction of mutant TP53 related genes in metabolic pathways and evaluation their correlation with immune cells, drug resistance and sensitivity.Semantic proximity
Select a neighboring publication to make it the new centre.